NASDAQ · Finance

Aimei Health Technology Co., Ltd. (AFJK)

At June 30, 2026 it held $1.5K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Price

$12.19

+0.04% on the day · September 25, 2026

52-week range $6.75 to $130.37

Market cap

$38.6M

What Aimei Health Technology Co., Ltd. does

Aimei Health Technology Co., Ltd. is registered with the SEC under industry code SIC 6770 (Blank Checks). Its shares trade on NASDAQ under the ticker AFJK.

Revenue and profit by year

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	n/a	-$835.8K	$1.1M	n/a	n/a
2024	n/a	-$1.1M	$2.6M	n/a	n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 17, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 18, 2025. Not a date the company has announced. See the report calendar

Latest SEC filings

What Aimei Health Technology Co., Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 3, 2026
New debt 8-K
August 25, 2026
Stock exchange listing notice 8-K
August 13, 2026
Quarterly report 10-Q · period to June 30, 2026Net loss of $83.1K versus net income of $425K.
August 10, 2026
Passive stake changed SCHEDULE 13G/A
August 6, 2026
New debt 8-K
July 8, 2026
Material agreement ended 8-K
July 6, 2026
New debt 8-K
June 29, 2026
Executive or director change 8-K
June 16, 2026
Quarterly report 10-Q · period to March 31, 2026Net income fell 75% to $45.4K.
June 4, 2026
New debt 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 1, 2026. Insider transactions on SEC

Who owns AFJK

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
First Trust Capital Management L.P.13G, passive with 3 related filers	21.48%	680,000	August 10, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about AFJK

What does Aimei Health Technology Co., Ltd. do?

Aimei Health Technology Co., Ltd. is registered with the SEC under industry code SIC 6770 (Blank Checks). Its shares trade on NASDAQ under the ticker AFJK.

Is Aimei Health Technology Co., Ltd. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $412.4K.

When did Aimei Health Technology Co., Ltd. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the new debt from September 3, 2026.

Similar companies

IPCX

Inflection Point Acquisition Corp. III

AVNI

Arvana Inc

MTAL

Metals Acquisition Corp. II

HCMA

Hcm III Acquisition Corp.

TACO

Berto Acquisition Corp.

CUB

Lionheart Holdings

Compare AFJK with

Compare AFJK with any company

Follow AFJK

Get an email when Aimei Health Technology Co., Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow AFJK: get an email when it files

Where the numbers come from

Financial figures are the values Aimei Health Technology Co., Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.